Risikobewertung von SARS-CoV-2 durch das RKI während der Pandemie

This procedure concerns the Robert Koch Institute's (RKI) risk assessment of the SARS-CoV-2 virus during the COVID-19 pandemic. It seeks to understand the scientific basis and methodology used by the RKI in evaluating the risks posed by the virus. The information is relevant to public health authorities, researchers, and citizens interested in the scientific response to the pandemic and the RKI's role in informing public health policy.